JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB113112

Anti-IFIT2 antibody

Be the first to review this product! Submit a review

|

(9 Publications)

Rabbit Polyclonal IFIT2 antibody. Suitable for WB and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Recombinant Fragment Protein within Human IFIT2 aa 100-350.

View Alternative Names

CIG-42, G10P2, IFI54, ISG54, IFIT2, Interferon-induced protein with tetratricopeptide repeats 2, IFIT-2, ISG-54 K, Interferon-induced 54 kDa protein, IFI-54K, P54

2 Images
Western blot - Anti-IFIT2 antibody (AB113112)
  • WB

Unknown

Western blot - Anti-IFIT2 antibody (AB113112)

All lanes:

Western blot - Anti-IFIT2 antibody (ab113112) at 1/1000 dilution

Lane 1:

Human fetal liver lysate

Lane 2:

Human fetal lung lysate

Predicted band size: 55 kDa

false

Western blot - Anti-IFIT2 antibody (AB113112)
  • WB

CiteAb

Western blot - Anti-IFIT2 antibody (AB113112)

IFIT2 western blot using anti-IFIT2 antibody ab113112. Publication image and figure legend from Pinkham, C., Dahal, B., et al., 2017, Sci Rep, PubMed 29085037.

ab113112 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab113112 please see the product overview.

Increases in host cellular mRNA does not correlate with increases in protein expression. (a) HSAECs were mock-infected or infected with MP12 for one hour. At 18 hours post infection, cell lysates were collected and analyzed by western blot. As a control, U937 cell lysates were used. At 24 hours post infection, cell lysates were collected and analyzed in parallel by western blot. Membranes were probed for levels of ARHGEF6 (α-PIX) and β-Actin as a loading control. (b) HSAECs were mock-infected, infected with MP12, or infected with MP12-ΔNSs for one hour. Following infection, cells were treated with Actinomycin D (1 µg/mL) for the remaining time. At 18 hours post infection, cell lysates were collected and analyzed in parallel by western blot for levels of IFIT2, Viperin, α-Actinin-2, and β-Actin as a loading control. Cropped, representative images are shown here. Uncropped western blots can be found in Supplemental Fig. 8.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Recombinant Fragment Protein within Human IFIT2 aa 100-350. The exact immunogen used to generate this antibody is proprietary information.

P09913

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/2000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Lyophilized
Reconstitution
Reconstitute in 200 µL of water
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

IFIT2 also known as Interferon-Induced Protein with Tetratricopeptide Repeats 2 functions as a critical player in antiviral defense mechanisms. This protein possesses a molecular mass of approximately 54 kDa. IFIT2 expression occurs mostly in cells that respond to type I interferons and during viral infections. The protein locates within the cytoplasm where it acts by recognizing non-self RNA aiding in the inhibition of viral replication.
Biological function summary

The protein exerts its influence by binding to RNA molecules lacking 2'-O-methylation a modification that is usually absent in viral RNA. IFIT2 works as both a solo entity and as part of a larger complex that includes other members like IFIT1 and IFIT3. The coordination among these proteins helps modulate the immune response influencing protein synthesis regulation in cells that are under viral attack.

Pathways

IFIT2 plays an essential role in the innate immune response particularly the interferon signaling pathway. It contributes to this pathway through its interactions with other proteins ensuring the rapid activation of antiviral states. Furthermore IFIT2 also connects to the toll-like receptor (TLR) signaling pathway playing a part in recognizing viral components. Through these pathways IFIT2 typically associates with proteins like TLR3 which facilitate detection and response to viral pathogens.

Chronic viral infections and certain types of cancer show a significant connection with IFIT2. In viral diseases reduced or impaired IFIT2 activity can lead to increased viral replication exacerbating the infection. This protein also gets involved in mechanisms affecting cancer progression often in connection with pathways involving the protein p53 a well-known tumor suppressor. The interaction between IFIT2 and these disease-related pathways highlights its potential as a target for therapeutic development.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

IFN-induced antiviral protein which inhibits expression of viral messenger RNAs lacking 2'-O-methylation of the 5' cap. The ribose 2'-O-methylation would provide a molecular signature to distinguish between self and non-self mRNAs by the host during viral infection. Viruses evolved several ways to evade this restriction system such as encoding their own 2'-O-methylase for their mRNAs or by stealing host cap containing the 2'-O-methylation (cap snatching mechanism). Binds AU-rich viral RNAs, with or without 5' triphosphorylation, RNA-binding is required for antiviral activity. Can promote apoptosis.
See full target information IFIT2

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

PLoS pathogens 18:e1010632 PubMed35789345

2022

Comparison of tissue tropism and host response to enteric and respiratory enteroviruses.

Applications

Unspecified application

Species

Unspecified reactive species

Ines Cordeiro Filipe,Han Kang Tee,Julien Prados,Isabelle Piuz,Samuel Constant,Song Huang,Caroline Tapparel

Nature communications 13:896 PubMed35173148

2022

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Karama Asleh,Gian Luca Negri,Sandra E Spencer Miko,Shane Colborne,Christopher S Hughes,Xiu Q Wang,Dongxia Gao,C Blake Gilks,Stephen K L Chia,Torsten O Nielsen,Gregg B Morin

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24:927-940 PubMed35107757

2022

STAT1/IFIT2 signaling pathway is involved in PD-L1-mediated epithelial-to-mesenchymal transition in human esophageal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

J Chen,Y Liu,Y Zhu,Y Chen,J Feng,T Jiang,X Zheng,L Chen,J Jiang

Journal of proteome research 21:459-469 PubMed34982558

2022

Deep Time Course Proteomics of SARS-CoV- and SARS-CoV-2-Infected Human Lung Epithelial Cells (Calu-3) Reveals Strong Induction of Interferon-Stimulated Gene Expression by SARS-CoV-2 in Contrast to SARS-CoV.

Applications

Unspecified application

Species

Unspecified reactive species

Marica Grossegesse,Daniel Bourquain,Markus Neumann,Lars Schaade,Jessica Schulze,Christin Mache,Thorsten Wolff,Andreas Nitsche,Joerg Doellinger

Translational cancer research 9:3214-3221 PubMed35117687

2020

Clinical significance of IFIT2 expression in human renal cancer tissues.

Applications

Unspecified application

Species

Unspecified reactive species

Bin Xu,Yu-Lan Zhu,Jia-Lin Fan,Lu-Jun Chen,Jing-Ting Jiang

OncoTargets and therapy 12:8139-8149 PubMed31632065

2019

Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Wenya Su,Wenlu Xiao,Lujun Chen,Qi Zhou,Xiao Zheng,Jingfang Ju,Jingting Jiang,Zhigang Wang

Molecular therapy : the journal of the American Society of Gene Therapy 26:755-773 PubMed29398485

2018

Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Zhao,Dan Li,Dandan Huang,Huajie Song,Hong Mei,Erhu Fang,Xiaojing Wang,Feng Yang,Liduan Zheng,Kai Huang,Qiangsong Tong

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 45:15-25 PubMed29316541

2018

Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Lujun Chen,Wensi Zhai,Xiao Zheng,Quanqin Xie,Qi Zhou,Min Tao,Yibei Zhu,Changping Wu,Jingting Jiang

Scientific reports 7:14385 PubMed29085037

2017

Alterations in the host transcriptome in vitro following Rift Valley fever virus infection.

Applications

Unspecified application

Species

Unspecified reactive species

Chelsea Pinkham,Bibha Dahal,Cynthia L de la Fuente,Nicole Bracci,Brett Beitzel,Michael Lindquist,Aura Garrison,Connie Schmaljohn,Gustavo Palacios,Aarthi Narayanan,Catherine E Campbell,Kylene Kehn-Hall
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com